NXTM News 12.27 Nxstage Medical (NXTM)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nxstage Medical (NXTM) 12.27 $NXTM

NxStage Patient Enjoys Travel and Active Lifestyle
PR Newswire - Tue Apr 15, 7:15AM CDT
NxStage Medical Inc., (NASDAQ: NXTM), a leading manufacturer of innovative home dialysis products, is proud to share current NxStage patient Henning's story of resilience and strength. For Henning, who has spent his life pursuing active and athletic endeavors around the world, more frequent home hemodialysis (HHD) with the NxStage® System One(TM) proved to be a good personal fit. Henning, a Danish citizen, has regained control of his life thanks to home hemodialysis. Currently he and his wife spend the majority of their time in New Hampshire and travel with the NxStage System One.

FDA Recommendations, Study Publications, Recognitions, Agreements, and Acquisitions - Analyst Notes on MannKind, Acceleron, Steris, Retrophin, and NxStage Medical
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding MannKind Corp. (NASDAQ: MNKD), Acceleron Pharma, Inc. (NASDAQ: XLRN), Steris Corp. (NYSE: STE), Retrophin, Inc. (NASDAQ: RTRX), and NxStage Medical, Inc. (NASDAQ: NXTM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

NxStage® to Report First Quarter 2014 Financial Results
PR Newswire - Tue Apr 08, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the first quarter ended March 31, 2014, on Thursday, May 8, 2014, before the opening of the financial markets.

Equities Updates on Top Gainers -- Research on Fresh Market, Alliance Fiber Optic Products, NxStage Medical, and UQM Technologies
PR Newswire - Thu Apr 03, 7:59AM CDT
On Wednesday, April 02, 2014, the US markets saw a positive sentiment, with the NASDAQ Composite closing at 4,276.46, up 0.20%, the Dow Jones Industrial Average ending the session at 16,573.00, up 0.24% and the S&P 500 edging 0.29% higher to finish the trading session at 1,890.90. The session saw a positive impact from Consumer Discretionary, Materials and Industrials sectors along with a drag from Information Technology, and Utilities sectors. A number of stocks saw large movements, including The Fresh Market Inc. (NASDAQ: TFM), Alliance Fiber Optic Products Inc. (NASDAQ: AFOP), NxStage Medical Inc. (NASDAQ: NXTM) and UQM Technologies Inc. (NYSE MKT: UQM). Free technical research on TFM, AFOP, NXTM and UQM can be downloaded upon signing up at:

NxStage Wins 2014 American Red Cross Northeast Chapter Workplace Hero Award
PR Newswire - Mon Mar 31, 7:37AM CDT
NxStage Medical Inc., a leading manufacturer of home dialysis products, today announced the Company has been awarded the 2014 Workplace Hero Award by the Northeast Chapter of the American Red Cross. Recognized for its commitment to community service over the course of 2013, NxStage distinguished itself from industry peers through continuous efforts to provide support for the disadvantaged and dedication to preparing employees to volunteer in the event of local and national disasters. The American Red Cross Northeast Chapter presented the award to NxStage for the first time at the 12th Annual Community Heroes Breakfast at the Doubletree by Hilton in Danvers, Massachusetts on March 20, 2014.

Uptrend Call Working As NxStage Medical Stock Rises 10.4% (NXTM)
Comtex SmarTrend(R) - Thu Mar 27, 9:31AM CDT
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 3 months, NxStage Medical has returned 10.38% as of today's recent price of $12.55.

NxStage Establishes First Annual National Home Hemodialysis Day
PR Newswire - Thu Mar 20, 7:00AM CDT
To build awareness for National Kidney Month, NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the first annual National Home Hemodialysis Day taking place today, March 20, 2014. In partnership with local and national kidney patient organizations, NxStage is encouraging the more than 26 million Americans1 that may have kidney disease and their supporters to wear a green ribbon to spread the word about kidney disease treatment options including home hemodialysis. In conjunction with this campaign, the Company is launching a national patient-to-patient outreach program called NxStage® + One(TM). This innovative initiative is based on the premise that one-to-one communication is the most compelling way to spread the word about the benefits of home hemodialysis.

NxStage Medical Up 21.6% Since SmarTrend Uptrend Call (NXTM)
Comtex SmarTrend(R) - Wed Mar 19, 5:00PM CDT
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 2 months, NxStage Medical has returned 21.64% as of today's recent price of $13.83.

Uptrend Call Working As NxStage Medical Stock Rises 21.8% (NXTM)
Comtex SmarTrend(R) - Wed Mar 12, 11:06AM CDT
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 2 months, NxStage Medical has returned 21.81% as of today's recent price of $13.85.

Downgrade Alert for NxStage Medical (NXTM)
Comtex SmarTrend(R) - Tue Mar 11, 6:58AM CDT
NxStage Medical (NASDAQ:NXTM) was downgraded from Market Perform to Underperform at Wells Fargo today. The stock closed yesterday at $14.66 on volume of 1.3 million shares, above average daily volume of 497,000. In the past 52 weeks, NxStage Medical share prices have been bracketed by a low of $8.77 and a high of $15.00 and closed yesterday at $14.66, 67% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.2% while the 200-day MA has remained constant.

US Market for Dialysis Equipment and Concentrates
M2 - Thu Mar 06, 3:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/npv4t6/u_s_market_for) has announced the addition of the "U.S. Market for Dialysis Equipment and Concentrates" report to their offering. The Total Dialysis Device And Concentrates Market Will Grow To A Value Of Almost $2 Billion By 2020 The total dialysis device and concentrates market includes the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, bloodlines, AV fistula needles, AV grafts, declotting devices, guidewires, introducer sheaths and water treatment systems. The market will grow as a result of increased patient populations. The patient populations of traditional incenter hemodialysis, home hemodialysis (HHD) and peritoneal dialysis are expected to grow over the forecast period. There will also be strong growth in the dry concentrates and heat disinfectant water treatment system market. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Reasons To Buy This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on a 'ground up' approach, which includes primary and secondary research methods. This report forecasts the development of the US market up to 2020. Key Topics Covered - Executive Summary - Research Methodology - US Dialysis Device And Concentrates Market - Hemodialysis Machine Market - Dialysis Catheter Market - Dialysis Concentrates Market - Dialyzer Market - Dialyzer Reprocessing Machine Market - Hemodialysis Bloodline And Tubing Set Market - Av Fistula Needle Market - Av Access Graft Market - Declotting Device Market - Introducer Sheath And Guidewire Market - Water Treatment System Market Companies Mentioned - AmeriWater - AngioDynamics - Argon Medical - Asahi Kasei Medical - B. Braun - Baxter - C. R. Bard - Cook Medical - Cordis - Covidien - Edwards Lifesciences - Fresenius - Gambro - Kawasumi Laboratories - LeMaitre - MAKY - MEDRAD - Mar Cor - Medcomp - Medisystems (NxStage Medical) - Medivators - NxStage Medical - Rockwell - Teleflex Medical - Terumo, - Vascular - W. L. Gore For more information visit http://www.researchandmarkets.com/research/np...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Shares of NXTM Up 25.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Mar 05, 9:41AM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 2 months, NxStage Medical has returned 25.95% as of today's recent price of $14.32.

U.S. Market for Dialysis Equipment and Concentrates (Executive Summary)
M2 - Fri Feb 28, 10:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/cbwzlh/u_s_market_for) has announced the addition of the U.S. Market for Dialysis Equipment and Concentrates (Executive Summary) report to their offering. This executive summary relates to the report U.S. Market for Dialysis Equipment and Concentrates. The total dialysis device and concentrates market will grow to a value of almost $2 billion over the forecast period. The total dialysis device and concentrates market includes the markets for hemodialysis machines, dialysis catheters, dialysis concentrates, dialyzers, dialyzer reprocessing machines, bloodlines, AV fistula needles, AV grafts, declotting devices, guidewires, introducer sheaths and water treatment systems. The market will grow as a result of increased patient populations. The patient populations of traditional incenter hemodialysis, home hemodialysis (HHD) and peritoneal dialysis are expected to grow over the forecast period. There will also be strong growth in the dry concentrates and heat disinfectant water treatment system market. This report pertains to a forecast period of 10 years (2010 - 2020) for the U.S. market. Scope of the Report - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback & Market Monitoring Main Segments Included - U.S. Dialysis Device and Concentrates Market - Hemodialysis Machine Market - Dialysis Catheter Market - Dialysis Concentrates Market - Dialyzer Market - Dialyzer Reprocessing Machine Market - Hemodialysis Bloodline and Tubing Set Market - AV Fistula Needle Market - AV Access Graft Market - Declotting Device Market - Introducer Sheath and Guidewire Market - Water Treatment System Market Reasons To Buy This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on a 'ground up' approach, which includes primary and secondary research methods. * Please note this is an executive summary only. The full report is available for purchase by following the link below. Key Topics Covered: 1. Executive Summary 1.1 U.S. Dialysis Device And Concentrates Market 1.2 Hemodialysis Machine Market 1.3 Dialysis Catheter Market 1.4 Dialysis Concentrates Market 1.5 Dialyzer Market 1.6 Dialyzer Reprocessing Machine Market 1.7 Hemodialysis Bloodline And Tubing Set Market 1.8 Av Fistula Needle Market 1.9 Av Access Graft Market 1.10 Declotting Device Market 1.11 Introducer Sheath And Guidewire Market 1.12 Water Treatment System Market 1.13 Competitive Analysis Companies Mentioned: - AmeriWater - AngioDynamics - Argon Medical - Asahi Kasei Medical - B. Braun - Baxter - C. R. Bard - Cook Medical - Cordis - Covidien - Edwards Lifesciences - Fresenius - Gambro - Kawasumi Laboratories - LeMaitre - MAKY - MEDRAD - Mar Cor - Medcomp - Medisystems (NxStage Medical) - Medivators - NxStage Medical - Rockwell - Teleflex Medical - Terumo, - Vascular - W. L. Gore For more information visit http://www.researchandmarkets.com/research/cb...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

NxStage Reports Record Fourth Quarter and Full-Year 2013 Financial Results
PR Newswire - Thu Feb 27, 6:31AM CST
NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported record financial results for the three and twelve months ended December 31, 2013, that include revenue slightly above its recent guidance.

BrainStorm Receives Additional $600,000 Non-Dilutive Grant From Israel's Office of the Chief Scientist
Marketwire - Tue Feb 25, 8:15AM CST
BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that BrainStorm Cell Therapeutics Ltd. was awarded an additional non-dilutive grant from Israel's Office of the Chief Scientist (OCS) for the year 2014 in the amount of $600,000. The grant is intended to support BrainStorm's clinical development for its innovative stem cell therapy candidate NurOwn(TM).

Former NxStage Patient Celebrates Life Milestones
PR Newswire - Mon Feb 24, 7:00AM CST
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, is proud to celebrate with former patient Laurie and her husband/care partner Mike two significant life milestones: their 30 year wedding anniversary and Laurie's second kidney transplant. For the couple, more frequent home hemodialysis (HHD) with the NxStage® System One(TM) proved to be a good personal fit for them. The convenience and flexibility of the therapy not only helped them stay focused on their lifestyle, but also gave them the opportunity to focus their collective energy on finding a second kidney donor. Laurie and Mike vowed when they first married for better or for worse, in sickness and in health, and Mike has stuck by Laurie's side with every step of her journey with kidney failure.

NxStage Medical Up 19.3% Since SmarTrend Uptrend Call (NXTM)
Comtex SmarTrend(R) - Tue Feb 18, 5:12PM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 1 month, NxStage Medical has returned 19.26% as of today's recent price of $13.56.

Students with Attention-Related Learning Challenges Significantly Increase Academic Performance using Digital Learning Tool in Atentiv School-Based Study
PR Newswire - Fri Feb 14, 7:17AM CST
Children with attention-related learning challenges can improve their academic performance and ability to complete school work at home and in school with the help of a new personalized digital learning tool, it was announced today at the Learning & The Brain conference unfolding in San Francisco where more than 1,000 educators, psychologists and neuroscientists are gathered. The study data were presented by Dr. Ned Hallowell, a child psychiatrist and author of numerous books on attention disorders, including "Driven to Distraction."

NxStage Medical Shares Up 12.1% Since SmarTrend's Buy Recommendation (NXTM)
Comtex SmarTrend(R) - Mon Feb 10, 9:29AM CST
SmarTrend identified an Uptrend for NxStage Medical (NASDAQ:NXTM) on January 9th, 2014 at $11.37. In approximately 1 month, NxStage Medical has returned 12.14% as of today's recent price of $12.75.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ontario Airport Braces for Holiday Travel Surge

Updated Category News Views 92

Gearing Up for a Thanksgiving Travel Boom Think Thanksgiving brings only turkey to the table? Down in Ontario, California, it's all about jet fuel and passenger counts. The Ontario International Airport (ONT) is where the skies are buzzing, forecasting over 227,000 passengers trying to soak up the holiday vibes by air. Compare that to the numbers when the local folks...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 71

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
First Time Homebuyer Tips for Southern Maryland Success

Updated Category News Views 54

Shaking Up First-Time Homebuyer Assumptions Ever hear that age-old nonsense about needing a fat stack of cash as a down payment before you can snag your first home? Yeah, turns out that's about as outdated as a rotary phone. Robin Cavallaro from RE/MAX Realty Group in Annapolis is setting the record straight for first-time buyers in Southern Maryland. Down Payment Myths...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 77

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 60

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 89

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Rock Tech Uncovers Major Lithium Discovery at Victory

Updated Category News Views 84

Rock Tech's Game-Changer at Victory Folks, we've got a shake-up in the lithium landscape over in Ontario, courtesy of Rock Tech Lithium Inc. They just unearthed something quite promising at their Victory Project: a spanking new spodumene-bearing pegmatite discovery. Now I know, if you're like me, you're thinking, 'What's the angle here?' Well, this isn't just another hole...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 152

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading
Kansai Powers Up US Grid with Bold Investment Move

Updated Category News Views 99

Betting Big on Battery Storage Let's unpack this big move by Kansai Electric. Anytime a major player like Kansai steps out of its home turf, folks better pay attention. Looks like Kansai's gotten cozy with Elevate and ArcLight, nabbing a minority stake in Prospect Power. This ain't your average widget factory—it's a beefy 150MW/600MWh battery energy storage facility in...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 109

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading

Top 5 Most Recently Viewed Articles

Algeness® VL Filler Receives Marketing Approval in China

Updated Category News Views 273

Exciting Developments for Advanced Aesthetic Technologies Advanced Aesthetic Technologies, Inc. (AAT) recently celebrated a significant milestone with the approval of their Algeness® VL agarose facial injection filler for marketing in China. This landmark achievement opens up new avenues for AAT in expanding their product offerings in the Asian market and showcases their...

Continue Reading
Criminal Charges Anticipated in Trump Campaign Hacking Case

Updated Category News Views 154

Criminal Charges Expected in Trump Campaign Hacking Case U.S. authorities are preparing to file criminal charges regarding an incident in which the Trump campaign claimed its internal communications were hacked, allegedly by the Iranian government. This concerning situation has drawn the attention of both the public and officials, raising serious issues surrounding...

Continue Reading
Semler Scientific Faces Class Action Lawsuit: What Investors Need to Know

Updated Category News Views 187

Semler Scientific and the Class Action Lawsuit Overview In recent news, a class action lawsuit has taken center stage involving Semler Scientific, Inc. (SMLR). Investors who have experienced losses related to their investments in Semler are advised to take note of this development, which may directly impact their financial outcomes. Understanding the Lawsuit This class...

Continue Reading
FTC Solar Engages Investors at Key Industry Conferences

Updated Category News Views 159

FTC Solar Engages Investors at Key Industry Conferences FTC Solar, Inc. (Nasdaq: FTCI), an innovative leader in solar tracker systems and engineering services, is set to make significant strides in connecting with investors at three prominent conferences. These events provide a platform for the management team, including CEO Yann Brandt, to engage in discussions that...

Continue Reading
Anixa Biosciences Set to Share Innovations in Cancer Therapy

Updated Category News Views 88

Anixa Biosciences Set to Conduct a Notable Presentation Anixa Biosciences, Inc. (NASDAQ: ANIX), a leading biotechnology firm dedicated to the treatment and prevention of cancer, has taken a significant step forward by announcing its participation in a prestigious investment conference. This event, the H.C. Wainwright 27th Annual Global Investment Conference, promises to...

Continue Reading